{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:43:22Z","timestamp":1778291002920,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clgc.2025.102361","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:53:48Z","timestamp":1744804428000},"page":"102361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the Performance of Systematic Sampling Combined With MRI-TRUS Fusion Biopsy and Concordance After Radical Prostatectomy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-0443","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Ayerra Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Fermin","family":"Barba Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Moreno Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Campa Bortolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egoitz","family":"Tolosa Eizaguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.clgc.2025.102361_bib0001","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2025.102361_bib0002","doi-asserted-by":"crossref","unstructured":"Rouvi\u00e8re O., Puech P., Renard-penna R., et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. 2019;20(January). doi:10.1016\/S1470-2045(18)30569-2","DOI":"10.1016\/S1470-2045(18)30569-2"},{"issue":"4","key":"10.1016\/j.clgc.2025.102361_bib0003","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane database Syst Rev"},{"issue":"10","key":"10.1016\/j.clgc.2025.102361_bib0004","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clgc.2025.102361_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.euo.2019.08.001","article-title":"Concordance between biopsy and radical prostatectomy pathology in the era of targeted biopsy: a systematic review and meta-analysis","volume":"3","author":"Goel","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"9","key":"10.1016\/j.clgc.2025.102361_bib0006","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw039","article-title":"Efficiency of prostate cancer diagnosis by MR\/ultrasound fusion-guided biopsy vs standard extended-sextant biopsy for MR-visible lesions","volume":"108","author":"Siddiqui","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.clgc.2025.102361_bib0007","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.juro.2013.12.007","article-title":"Improving detection of clinically significant prostate cancer: magnetic resonance imaging \/transrectal ultrasound fusion guided prostate biopsy","volume":"191","author":"Rastinehad","year":"2014","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102361_bib0008","first-page":"150.e1","article-title":"Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: a prospective development study","volume":"35","author":"Valerio","year":"2017","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"5","key":"10.1016\/j.clgc.2025.102361_bib0009","first-page":"2221","article-title":"Value of three biopsy methods in prostate cancer detection: a meta-analysis and systematic review","volume":"25","author":"Deng","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"4","key":"10.1016\/j.clgc.2025.102361_bib0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bju.15093","article-title":"Detection of clinically significant prostate cancer in biopsy-na\u00efve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy","volume":"126","author":"Mannaerts","year":"2020","journal-title":"BJU International"},{"issue":"7","key":"10.1016\/j.clgc.2025.102361_bib0011","article-title":"Is targeted magnetic resonance imaging\/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS \u22653: results of a prospective, randomized clinical trial","volume":"16","author":"Zhang","year":"2020","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"10.1016\/j.clgc.2025.102361_bib0012","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bju.13247","article-title":"The value of magnetic resonance imaging and ultrasonography (MRI\/US)-fusion biopsy platforms in prostate cancer detection: a systematic review","volume":"117","author":"Gayet","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2025.102361_bib0013","article-title":"MRI\/transrectal ultrasound fusion-guided targeted biopsy and transrectal ultrasound-guided systematic biopsy for diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102361_bib0014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41391-021-00449-7","article-title":"Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis","volume":"25","author":"Bass","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2025.102361_bib0015","doi-asserted-by":"crossref","unstructured":"Yamada Y., Ukimura O., Kaneko M., Matsugasumi T., Fujihara A. Moving away from systematic biopsies : image \u2011 guided prostate biopsy (in \u2011 bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) \u2014 literature review. 2020;(0123456789). https:\/\/doi.org\/10.1007\/s00345-020-03366-x.","DOI":"10.1007\/s00345-020-03366-x"},{"issue":"1","key":"10.1016\/j.clgc.2025.102361_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00330-017-4939-0","article-title":"Incremental diagnostic value of targeted biopsy using mpMRI-TRUS fusion versus 14-fragments prostatic biopsy: a prospective controlled study","volume":"28","author":"Mariotti","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clgc.2025.102361_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.euros.2022.04.001","article-title":"Diagnostic performance of a Magnetic resonance imaging-directed targeted plus regional biopsy approach in prostate cancer diagnosis: a systematic review and meta-analysis","volume":"40","author":"Hagens","year":"2022","journal-title":"Eur Urol open Sci"},{"key":"10.1016\/j.clgc.2025.102361_bib0018","doi-asserted-by":"crossref","unstructured":"Porreca A., GF Del, Giampaoli M., et al. Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs. 2020;37(July). https:\/\/doi.org\/10.1097\/MD.0000000000022059.","DOI":"10.1097\/MD.0000000000022059"},{"issue":"3","key":"10.1016\/j.clgc.2025.102361_bib0019","first-page":"326","article-title":"The current and future role of magnetic resonance imaging in prostate cancer detection and management","volume":"4","author":"Radtke","year":"2015","journal-title":"Transl Androl Urol"},{"issue":"10","key":"10.1016\/j.clgc.2025.102361_bib0020","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00345-019-02634-9","article-title":"A multicentric study on accurate grading of prostate cancer with systematic and MRI\/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy","volume":"37","author":"Diamand","year":"2019","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102361_bib0021","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.euo.2023.04.004","article-title":"Impact of Magnetic resonance imaging targeting on pathologic upgrading and downgrading at prostatectomy: a systematic review and meta-analysis","volume":"6","author":"Weinstein","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clgc.2025.102361_bib0022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.urology.2018.02.029","article-title":"Assessment of discomfort and pain in patients undergoing fusion magnetic resonance imaging-guided vs TRUS-guided prostate biopsy","volume":"116","author":"Robins","year":"2018","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.clgc.2025.102361_bib0023","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.euo.2018.02.005","article-title":"Patient experience of systematic versus fusion prostate biopsies","volume":"1","author":"Eineluoto","year":"2018","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102361_bib0024","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.euo.2019.08.007","article-title":"Complications and adverse events of three Magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: results from the FUTURE trial, a multicentre randomised controlled trial","volume":"2","author":"Wegelin","year":"2019","journal-title":"Eur Urol Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732500062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732500062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:52:56Z","timestamp":1752609176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876732500062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S155876732500062X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102361","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Performance of Systematic Sampling Combined With MRI-TRUS Fusion Biopsy and Concordance After Radical Prostatectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102361"}}